<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01041547</url>
  </required_header>
  <id_info>
    <org_study_id>F091023002</org_study_id>
    <nct_id>NCT01041547</nct_id>
  </id_info>
  <brief_title>Vascular Function, Insulin Sensitivity, and Vitamin D</brief_title>
  <acronym>VIVID</acronym>
  <official_title>Vitamin D, Vascular Function, and Insulin Sensitivity in Adults [The VIVID Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objectives of this study are to examine the relationships between circulating
      vitamin D, insulin sensitivity, and multiple indices of vascular function and to examine
      whether vitamin D deficiency in African Americans (AA) and White Hispanics (WH) is
      responsible for ethnic differences in insulin sensitivity and hypertension in AA, WH and
      European Americans (EA), as well as mechanisms underlying the association between insulin
      resistance and blood pressure. We hypothesize that 1) serum 25(OH)D is associated with
      insulin sensitivity and vascular functioning, independent of adiposity, 2) lower insulin
      sensitivity and vascular functioning in AA and WH relative to EA is due to lower circulating
      25(OH)D in AA, and 3) the relationship between insulin resistance and vascular dysfunction is
      mediated by 25(OH)D.

      Acronyms: African American (AA), European American (EA), White Hispanics (WH), Serum
      25-hydroxy vitamin D (25()H)D, Body mass index (BMI), Alabama (AL).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>Cross sectional study: at first study visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vascular function</measure>
    <time_frame>Cross sectional study: at second study visit, within 2 weeks of first study visit</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">63</enrollment>
  <condition>Insulin Sensitivity</condition>
  <condition>Flow-mediated Dilation</condition>
  <condition>Arterial Stiffness</condition>
  <arm_group>
    <arm_group_label>Healthy adults</arm_group_label>
    <description>healthy adults with BMI below 32, between ages 19-60 yrs, both males and females</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Seum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        -  Healthy adults with BMI below 32

          -  Both males and females

          -  Ages 19-60 years

          -  Race: African Americans, White Hispanics, European Americans
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  African American (AA), White Hispanic (WH), and European American (EA) race

          -  Ages 19-60 years

          -  Negative urine pregnancy test

          -  No evidence of diabetes

          -  Not on medications that can affect vascular functioning or insulin sensitivity

        Exclusion Criteria:

          -  BMI &gt; 32 kg/m2

          -  Diabetes or any chronic diseases

          -  Use of medication(s) known to influence body composition, vascular function, or
             glucose metabolism

          -  Regular smoking

          -  Regular use of illegal drugs and pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ambika Ashraf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 28, 2009</study_first_submitted>
  <study_first_submitted_qc>December 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2009</study_first_posted>
  <last_update_submitted>January 13, 2014</last_update_submitted>
  <last_update_submitted_qc>January 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Ambika Ashraf, M.D.</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Insulin sensitivity</keyword>
  <keyword>Vascular function</keyword>
  <keyword>Flow-mediated dilation</keyword>
  <keyword>Arterial stiffness</keyword>
  <keyword>Glucose tolerance</keyword>
  <keyword>Hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

